KR100425525B1 - 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트 - Google Patents

조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트 Download PDF

Info

Publication number
KR100425525B1
KR100425525B1 KR10-2000-0069283A KR20000069283A KR100425525B1 KR 100425525 B1 KR100425525 B1 KR 100425525B1 KR 20000069283 A KR20000069283 A KR 20000069283A KR 100425525 B1 KR100425525 B1 KR 100425525B1
Authority
KR
South Korea
Prior art keywords
mmp
diagnostic
concentration
amniotic fluid
fetal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR10-2000-0069283A
Other languages
English (en)
Korean (ko)
Other versions
KR20020039458A (ko
Inventor
윤보현
Original Assignee
재단법인서울대학교산학협력재단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR10-2000-0069283A priority Critical patent/KR100425525B1/ko
Application filed by 재단법인서울대학교산학협력재단 filed Critical 재단법인서울대학교산학협력재단
Priority to JP2002544659A priority patent/JP4011479B2/ja
Priority to CNB018192696A priority patent/CN1245626C/zh
Priority to AU2001275820A priority patent/AU2001275820A1/en
Priority to PCT/KR2001/001306 priority patent/WO2002042770A1/en
Priority to US10/415,763 priority patent/US7232661B2/en
Priority to EP01953363A priority patent/EP1336103A4/en
Publication of KR20020039458A publication Critical patent/KR20020039458A/ko
Application granted granted Critical
Publication of KR100425525B1 publication Critical patent/KR100425525B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR10-2000-0069283A 2000-11-21 2000-11-21 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트 Expired - Lifetime KR100425525B1 (ko)

Priority Applications (7)

Application Number Priority Date Filing Date Title
KR10-2000-0069283A KR100425525B1 (ko) 2000-11-21 2000-11-21 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
CNB018192696A CN1245626C (zh) 2000-11-21 2001-08-01 产前诊断早产、胎儿感染和胎儿损伤的诊断剂及含有它们的诊断试剂盒
AU2001275820A AU2001275820A1 (en) 2000-11-21 2001-08-01 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same
PCT/KR2001/001306 WO2002042770A1 (en) 2000-11-21 2001-08-01 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same
JP2002544659A JP4011479B2 (ja) 2000-11-21 2001-08-01 早産、胎児感染及び胎児損傷の産前診断用診断試薬及びこれを含む診断キット
US10/415,763 US7232661B2 (en) 2000-11-21 2001-08-01 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same
EP01953363A EP1336103A4 (en) 2000-11-21 2001-08-01 DIAGNOSIS FOR THE PRENATAL DIAGNOSIS OF SPRING BIRTHS, FUSION INFECTIONS AND FATTILLAGE DAMAGES AND DIAGNOSIS KIT THEREWITH

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0069283A KR100425525B1 (ko) 2000-11-21 2000-11-21 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트

Publications (2)

Publication Number Publication Date
KR20020039458A KR20020039458A (ko) 2002-05-27
KR100425525B1 true KR100425525B1 (ko) 2004-03-30

Family

ID=19700313

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0069283A Expired - Lifetime KR100425525B1 (ko) 2000-11-21 2000-11-21 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트

Country Status (7)

Country Link
US (1) US7232661B2 (enExample)
EP (1) EP1336103A4 (enExample)
JP (1) JP4011479B2 (enExample)
KR (1) KR100425525B1 (enExample)
CN (1) CN1245626C (enExample)
AU (1) AU2001275820A1 (enExample)
WO (1) WO2002042770A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240083552A (ko) 2022-12-05 2024-06-12 주식회사 제이스텍 진단키트용 비드의 공급 및 투입장치

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2231791C2 (ru) * 2002-09-26 2004-06-27 Ахмадеева Эльза Набиахметовна Способ диагностики внутриутробной инфекции новорожденных
GB2435511A (en) * 2006-02-23 2007-08-29 Mologic Ltd Protease detection
GB2435510A (en) 2006-02-23 2007-08-29 Mologic Ltd Enzyme detection product and methods
GB2435512A (en) 2006-02-23 2007-08-29 Mologic Ltd A binding assay and assay device
GB2437311A (en) * 2006-04-07 2007-10-24 Mologic Ltd A protease detection product
CN104645328A (zh) 2006-10-03 2015-05-27 建新公司 TGF-β拮抗物治疗具有罹患支气管肺发育不良风险的婴儿的用途
US8828950B2 (en) * 2007-05-01 2014-09-09 Cedars-Sinai Medical Center Caspase inhibitors in the treatment of infection-associated preterm delivery
CN104777307B (zh) * 2008-10-31 2019-10-18 耶鲁大学 先兆子痫检测和治疗的方法和组合物
US20120238469A1 (en) * 2009-12-08 2012-09-20 Cedars-Sinai Medical Center Diagnostic biomarker to identify women at risk for preterm delivery
EP2686681B1 (en) 2011-03-17 2016-11-16 Cedars-Sinai Medical Center Diagnostic biomarker to predict women at risk for preterm delivery
CN105324666B (zh) * 2013-05-16 2018-07-27 和卓生物科技（上海）有限公司 使用来自母体血液的胎儿细胞捕获的胎儿诊断学
US20160130553A1 (en) 2014-05-15 2016-05-12 Kellbenx Incorporated PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
US12202890B1 (en) 2014-11-07 2025-01-21 Kellbenx Incorporated Antibodies for detection and enrichment of fetal cells and their use
CN104498431B (zh) * 2015-01-23 2017-10-20 温州市中心医院 一种载玻片原位培养羊水细胞及核型处理分析的方法
KR101578526B1 (ko) * 2015-07-14 2015-12-17 이화여자대학교 산학협력단 32주 미만의 조산 위험성을 예측하기 위한 마커 il-13 및 이의 이용
KR101695347B1 (ko) 2015-10-12 2017-01-11 이화여자대학교 산학협력단 유전자의 CpG 메틸화 변화를 이용한 조산 위험성 예측용 조성물 및 이의 이용
KR101589673B1 (ko) * 2015-10-12 2016-01-28 (주)휴레이포지티브 시약 키트의 이미지를 통한 감염병 진단 방법 및 장치
US9662257B1 (en) 2015-11-06 2017-05-30 Amnion Life, LLC Premature infant amniotic bath incubator
CA3046414A1 (en) * 2016-12-23 2018-06-28 Susanne Pangratz-Fuhrer Alpha-b crystallin in the diagnosis of neonatal brain damage
EP3631460B1 (en) 2017-05-31 2023-11-15 B.R.A.H.M.S GmbH Mmp-8 as a marker for identifying infectious disease
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
EP3971573A1 (en) 2017-09-13 2022-03-23 B.R.A.H.M.S GmbH Proadrenomedullin as a marker for abnormal platelet levels
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
RU2687486C1 (ru) * 2018-02-05 2019-05-14 Федеральное государственное бюджетное образовательное учреждение высшего образования Кубанский государственный медицинский университет Министерства Здравоохранения Российской Федерации (ФГБОУ ВО КУбГМУ МЗ РФ) Способ определения степени риска внутриутробной инфекции плода у женщин, перенесших грипп A(H1N1) в период беременности
KR102184911B1 (ko) * 2019-06-07 2020-12-01 한림대학교 산학협력단 miR-548을 함유하는 조산 예방 또는 치료제 조성물
CN111513729B (zh) * 2020-05-07 2021-04-27 吉林大学 一种高效的产前诊断间期胎儿细胞检测装置
KR102339013B1 (ko) * 2020-11-16 2021-12-14 주식회사 옵티바이오 양수 검체 내 mmp-8 정량화가 가능한 체외 진단 키트

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240083552A (ko) 2022-12-05 2024-06-12 주식회사 제이스텍 진단키트용 비드의 공급 및 투입장치

Also Published As

Publication number Publication date
KR20020039458A (ko) 2002-05-27
CN1245626C (zh) 2006-03-15
JP2004522942A (ja) 2004-07-29
AU2001275820A1 (en) 2002-06-03
CN1476537A (zh) 2004-02-18
EP1336103A4 (en) 2007-05-09
US7232661B2 (en) 2007-06-19
US20040029176A1 (en) 2004-02-12
WO2002042770A1 (en) 2002-05-30
EP1336103A1 (en) 2003-08-20
JP4011479B2 (ja) 2007-11-21

Similar Documents

Publication Publication Date Title
KR100425525B1 (ko) 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
Friel et al. The calcium binding protein, S100B, is increased in the amniotic fluid of women with intra-amniotic infection/inflammation following preterm labor with intact or ruptured membranes
Muller et al. Development of human renal function: reference intervals for 10 biochemical markers in fetal urine
Goldenberg et al. Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation and subsequent spontaneous preterm birth
Babay et al. Serum cystatin C in pregnant women: reference values, reliable and superior diagnostic accuracy
US20040014063A1 (en) Il-6 detection for predicting risks of preterm delivery
US6174664B1 (en) Screening method for inflammatory diseases using neutrophil defensins and lactoferrin
Kayem et al. Detection of interleukin-6 in vaginal secretions of women with preterm premature rupture of membranes and its association with neonatal infection: a rapid immunochromatographic test
RU2469331C1 (ru) Способ прогнозирования угрозы прерывания беременности в 1 триместре
Fukunaga et al. MMP‐9 and TIMP‐1 in the cord blood of premature infants developing BPD
Platz-Christensen et al. Increased prostaglandin concentrations in the cervical mucus of pregnant women with bacterial vaginosis
Torbé et al. Are vaginal fluid procalcitonin levels useful for the prediction of subclinial infection in patients with preterm premature rupture of membranes?
RU2695356C1 (ru) Способ прогнозирования состояния плода при преждевременном разрыве плодных оболочек с 24 до 33 недель беременности
Kumar et al. Dynamic alteration in the vaginal secretory proteome across the early and mid-trimesters of pregnancy
US8859216B2 (en) Method for noninvasive prediction or diagnosis of inflammation and infection in amniotic fluid of patients with premature rupture of membranes
Sisti et al. Insulin-like growth factor binding protein-1 predicts preterm premature rupture of membranes in twin pregnancies
RU2290644C1 (ru) Способ прогнозирования церебральных нарушений у новорожденных от матерей из группы высокого риска
CN101680899A (zh) 通过粪便中幽门螺杆菌抗原的定量测定来判断胃粘膜状态的方法
Chepanov et al. Characteristics of autoantibodies associated with recurrent pregnancy loss
Katsura et al. Amniotic fluid neutrophil gelatinase‐associated lipocalin and L‐type fatty acid‐binding protein in predicting fetal inflammatory response syndrome
RU2225007C1 (ru) Способ прогнозирования исхода сепсиса у новорожденных
RU2304783C1 (ru) Способ прогнозирования развития гестоза
Ogino et al. Establishment of a prediction method for premature rupture of membranes in term pregnancy using active ceruloplasmin in cervicovaginal secretion as a clinical marker
RU2287823C1 (ru) Способ прогнозирования гестоза
Porstmann et al. Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20001121

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20030129

Patent event code: PE09021S01D

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20030312

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20030927

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20030129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20031027

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20030927

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20040119

Appeal identifier: 2003101004224

Request date: 20031027

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20031126

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20031027

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20030429

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20040119

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20031217

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20040319

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20040322

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20070305

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20080226

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20090227

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20100226

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20110302

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20120910

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20130318

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20130318

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20140305

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20140305

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20150213

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20150213

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20160217

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20160217

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20170315

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20180118

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20180118

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20190124

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20190124

Start annual number: 16

End annual number: 16

FPAY Annual fee payment

Payment date: 20200103

Year of fee payment: 17

PR1001 Payment of annual fee

Payment date: 20200103

Start annual number: 17

End annual number: 17

PC1801 Expiration of term